« Zurück
Startseite /
CD30 Ligand / TNFSF8 Recombinant Protein

CD30 Ligand / TNFSF8 Recombinant Protein

749,00 €

Zzgl. MwSt.

ArtNr	PRS-11-332-0.1mg
Hersteller	ProSci
Menge	0.1 mg
Kategorie	Oncology By Cell Type Hematology Leukemia Lymphoma Peptides & Proteins Recombinant Proteins Mesothelioma Western Blot ELISA
Typ	Proteins Recombinant
Format	Lyophilized
Applikationen	WB, ELISA
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	CD30-L,CD153,TNFSF8,CD30L,CD30LG,CD153 antigen,CD30 antigen ligand,CD30 Ligand
Lieferbar
Applications	This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 21.5 kDa. The protein migrates as 30-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Applications	This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 21.5 kDa. The protein migrates as 30-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Buffer	PBS, pH7.4
Storage Conditions	Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles.
Disclaimer	Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.
Predicted Molecular Weight	21.5 kDa
Purity	>90% as determined by SDS-PAGE.
Background	CD30 ligand (CD30L) and CD30 are interacting cellsurface glycoproteins that are members of the tumour necrosis factor (TNF) and tumour necrosis factor receptor(TNFR) superfamilies. In humans, CD30L is expressed at high levels on activated T cells. There is conflicting evidence with regard to cell surface expression of CD30L on primary human B cells. An initial report of constitutive CD30L expression on peripheral blood B cells33 has not been substantiated.
1St Image Caption3	Human CD30 Ligand, His Tag, low endotoxin on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
3Rd Image Caption	Immobilized Human CD30 Ligand, His Tag, low endotoxin at 2 ug/mL (100 uL/well) can bind Human CD30, Llama IgG2b Fc Tag, low endotoxin with a linear range of 0.6-10 ng/mL (Routinely tested).
Background References 1	Marín ND., et al. 2017, Tuberculosis (Edinb)., 102, 8-15.
Background References 2	Kennedy MK., et al. 2006, Immunology., 118(2), 143-52.
Background References 3	Horie R., et al. 1998, Semin Immunol., 10(6), 457-70.
Accession #	NP_003799.1
Ncbi Gene Id #	8741
Ncbi Official Symbol	TNFSF13
Ncbi Official Full Name	TNF superfamily member 13
Ncbi Organism	Homo sapiens
Swissprot #	O75888
Fusion Tag	His Tag
Sequence	Gln 63 - Asp 234

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 0.1 mg

Listenpreis: 749,00 €

Preis: 749,00 €

lieferbar

Lieferung vsl. bis 02.10.2025

Anzahl:

Vergleichen